𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Scribed by Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris


Publisher
Springer
Year
2010
Tongue
English
Weight
244 KB
Volume
67
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES